LivaNova PLC | Key People and Executives
Daniel Jeffrey Moore
Non-Executive Chairman
Damien McDonald
Chief Executive Officer & Executive Director
Andrea L. Saia
Independent Director
Arthur L. Rosenthal
Independent Director
Sharon O'Kane
Independent Director
Alfred J. Novak
Independent Director
Hugh M. Morrison
Independent Director
Francesco Bianchi
Independent Director
Daniel Jeffrey Moore
Non-Executive Chairman
Damien McDonald
Chief Executive Officer & Executive Director
Thad Huston
Chief Financial Officer
David S. Wise
Chief Administrative Officer
Alistair Simpson
General Manager-Cardiac Surgery
Edward S. Andrle
General Manager-Neuromodulation
Matt J. Dodds
Senior Vice President-Corporate Development
Paul R. Buckman
General Manager-TMVR
Douglas John Manko
Chief Accounting Officer
Piero Vecchi
Vice President & Controller
Deanna Wilke
Director-Corporate Communications
Karen M. King
Vice President-Investor Relations & Communications
Keyna P. Skeffington
Senior Vice President & General Counsel
Bryan D. Olin
SVP-Clinical, Quality & Regulatory Affairs
Andrea L. Saia
Independent Director
Arthur L. Rosenthal
Independent Director
Sharon O'Kane
Independent Director
Alfred J. Novak
Independent Director
Hugh M. Morrison
Independent Director
Francesco Bianchi
Independent Director
| Address |
20 Eastbourne Terrace
London Greater London W2 6LG
United Kingdom
|
|
Employees
|
- |
| Website |
http://www.livanova.com |
| Updated |
07/08/2019 |
| LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the Cardiac Surgery and Neuromodulation, and Other Corporate segments. The Cardiac Surgery and Neuromodulation segment corresponds to the primary therapeutic areas. |
